European review for medical and pharmacological sciences
Mar 1, 2021
OBJECTIVE: As we know, gallstones are a gallbladder disease with high incidence around the world. As the population has aged and living habits have changed, the incidence of the disease is increasing year by year. Gallstones are mainly classified int...
European review for medical and pharmacological sciences
Jan 1, 2021
OBJECTIVE: Diabetic Retinopathy (DR) is a highly threatening microvascular complication of diabetes mellitus. Diabetic patients must be screened annually for DR; however, it is practically not viable due to the high volume of patients, lack of resour...
European review for medical and pharmacological sciences
Dec 1, 2020
OBJECTIVE: Patients with acute severe and medical refractory ulcerative colitis have a high risk of postoperative complications after total abdominal colectomy (TAC). The objective of this retrospective study is to use machine learning to analyze and...
European review for medical and pharmacological sciences
Nov 1, 2020
Researchers have found many similarities between the 2003 severe acute respiratory syndrome (SARS) virus and SARS-CoV-19 through existing data that reveal the SARS's cause. Artificial intelligence (AI) learning models can be created to predict drug s...
European review for medical and pharmacological sciences
Nov 1, 2020
Recent Coronavirus (COVID-19) is one of the respiratory diseases, and it is known as fast infectious ability. This dissemination can be decelerated by diagnosing and quarantining patients with COVID-19 at early stages, thereby saving numerous lives. ...
European review for medical and pharmacological sciences
Oct 1, 2020
OBJECTIVE: A prediction of the number of patients with conjunctivitis plays an important role in providing adequate treatment at the hospital, but such accurate predictive model currently does not exist. The current study sought to use machine learni...
European review for medical and pharmacological sciences
Sep 1, 2020
Today, the world suffers from the rapid spread of COVID-19, which has claimed thousands of lives. Unfortunately, its treatment is yet to be developed. Nevertheless, this phenomenon can be decelerated by diagnosing and quarantining patients with COVID...
European review for medical and pharmacological sciences
Jul 1, 2020
The 2019 Novel Coronavirus disease (COVID-19) broke out in Wuhan, China in December 2019 and spread throughout the world. Early screening and early diagnosis play key roles in prevention and management of the epidemic. Attention should also be paid t...
European review for medical and pharmacological sciences
Jul 1, 2020
OBJECTIVE: Although highly successful, the medical R&D model is failing at improving people's health due to a series of flaws and defects inherent to the model itself. A new collective intelligence, incorporating human and artificial intelligence (AI...
European review for medical and pharmacological sciences
Feb 1, 2020
OBJECTIVE: The morbidity and mortality of patients with colorectal cancer, one of the most common malignant tumors worldwide, is steadily increasing. The aim of this study was to investigate the association between prognostic immune-related gene prof...